Abstract:Abstract BACKGROUND Inflammatory bowel disease (IBD)-associated arthritis affects over 25% of those with IBD and is associated with several risk factors including disease location. The intestinal microbiome varies throughout the intestinal tract and is thought to play a role in the development of IBD, although the precise mechanism remains unexplored. To better characterize its relationship with IBD-associated arthritis, we analyzed the intestinal microbiome from a subset of subjects in the LOCATION-IBD cohort. METHODS Microbiome analysis was performed on 16S rRNA V3V4 amplicon sequencing data generated from mucosal biopsies from the terminal ileum (TI), hepatic flexure (HF), and the distal descending colon (DDC) of participants in the LOCATION-IBD cohort. Alpha diversity was assessed using the Shannon index, while beta diversity between samples from the same participant were assessed using Jenson-Shannon Divergence (JSD). ZicoSeq was used to assess differential abundances in composition between those with vs without IBD-associated arthritis. RESULTS In this analysis, we included a subset of samples from participants in the LOCATION-IBD cohort with (n= 68 from 25 participants) and without (n = 86 from 29 participants) joint EIMs and with joint pain of unclear etiology (n= 14 from 5 participants). Overall, samples clustered predominantly based on participant, and similar genera were present across TI, HF, and DDC mucosal samples. Shannon diversity was similar across samples, regardless of the associated arthritis category, though diversity was lower in those with CD compared to those with UC (p-value = 0.0007, Tukey post-hoc p-value = 0.0004) and trended to be higher in sites of inflammation (p-value = 0.0645). JSDs between samples for an individual participant were higher for those with compared to those without IBD-associated arthritis (p-value = 0.038). In those with joint EIMs, Flavonifractor and Fusicatenibacter were significantly lower without accounting for sampling location, whereas other species including Lachnoclostridium (increased) and Fusobacterium (decreased) were noted in the proximal colon. CONCLUSIONS To our knowledge, this represents the first assessment of the mucosal microbiome across several intestinal sites in individuals with and without IBD-associated arthritis. Our finding that similar bacteria are found across the terminal ileum, proximal colon, and distal colon, but that less site-to-site concordance is seen in those with IBD-associated arthritis, aligns with previous findings that the involvement of specific colonic segments is associated with IBD-associated arthritis. Further, our finding that the abundances of specific bacteria are altered, frequently in a site-specific manner, identifies potential opportunities for future studies.

P1228 The EISER Study: Identifying Microbial Factors Associated with Subclinical Gut Inflammation in Psoriatic Arthritis Patients Who Develop Inflammatory Bowel Disease

DOP60 Prevalence of undiagnosed inflammatory Bowel Disease in patients with spondyloarthritis: EISER Study

Elevated Calprotectin Levels Reveal Loss of Vascular Pattern and Atrophy of Villi in Ileum by Digital Chromoendoscopy and Magnification Colonoscopy in Patients with Spondyloarthritis Without Having Inflammatory Bowel Disease

Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25-Driven Intestinal Inflammation

P179 Decrease in Butyric Acid in fecal matter in patients with Inflammatory Bowel Disease is associated with the levels of secretory Immunoglobulin A and fecal calprotectin

P715 Multiparametric assessment of IBD and SpA-IBD patients to explore disease biomarkers and response predictors

Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota

[Faecal microbiota study reveals specific dysbiosis in spondyloarthritis according to subtype, disease activity and treatment]

Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile

THE COLONIC MUCOSAL MICROBIOME IN IBD-ASSOCIATED ARTHRITIS IS MORE VARIABLE THAN IN IBD ALONE

IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation.

P010 Faecal microbiota composition by shotgun metagenomic sequencing approach in a newly diagnosed cohort of inflammatory bowel disease patients: results from the IBDomics project

Prevalence of spondyloarthritis in inflammatory bowel disease according ASAS and ultrassonography and its correlation with plasma calprotectin

P1158 Comparison of comorbidities, and lifestyle habits between IBD patients, IBD patients with suspected SpA, and controls

P1211 A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn’s Disease

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease

Study of gut microbiome alterations in plaque psoriasis patients compared to healthy individuals

A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways

Gut microbiota differences between psoriatic arthritis and other undifferentiated arthritis: A pilot study

Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents

Eubacterium rectale is a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis